Dry Eye Syndrome Market Size to Boost USD 10.55 Billion By 2032 | CAGR 7.3% Published by Emergen Research

The Global Dry Eye Syndrome Market size was USD 5.32 billion in 2022 and is expected to register a revenue CAGR of 7.3% during the forecast period. Increasing cases of dry eye syndrome across the globe, widespread use of digital devices, such as computers, smartphones, and tablets, numerous Research & Development (R&D) activities by market players, rising demand for effective treatments, and strong R&D investments to support pipeline candidates are expected to drive market revenue growth.

The dry eye syndrome market is a growing segment within the global ophthalmic industry, driven by the increasing prevalence of dry eye disease worldwide. Dry eye syndrome (DES), also known as keratoconjunctivitis sicca, occurs when the eyes fail to produce enough tears or when the tears evaporate too quickly, leading to discomfort, inflammation, and potential damage to the eye's surface. The condition is widespread, particularly among older adults, and its prevalence is expected to rise due to factors such as aging populations, increased screen time, and environmental pollution. The global market for dry eye treatments encompasses a wide range of therapeutic options, including artificial tears, anti-inflammatory drugs, punctal plugs, and surgical interventions.

 The report is attuned with the latest market changes and economic landscape with regard to the currently unfolding COVID-19 pandemic. The crisis has affected the demand and supply pattern, as well as the trends of the industry. It has also brought an economic slowdown that has affected the business of the key manufacturers of the industry. The report estimates the impact of this crisis on the current scenario and future prospects and provides a post-COVID market scenario.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2706

Drivers of the Dry Eye Syndrome Market :

Several key factors are driving the growth of the dry eye syndrome market. One of the most significant drivers is the increasing incidence of the condition, particularly in aging populations. As people age, the natural production of tears decreases, making older individuals more susceptible to dry eye disease. The global population is aging rapidly, and with it, the prevalence of age-related conditions like dry eye syndrome is expected to increase, fueling demand for treatment options.Another crucial driver is the growing use of digital devices such as computers, smartphones, and tablets. Prolonged screen time can lead to digital eye strain, which is a major contributing factor to dry eye syndrome. As more people rely on digital devices for work, communication, and entertainment, the incidence of dry eye disease is rising, particularly among younger populations. This trend is expected to drive the demand for over-the-counter and prescription treatments for dry eye syndrome.

 Restraints of the Dry Eye Syndrome Market :

Despite its growth potential, the dry eye syndrome market faces several challenges. One of the primary restraints is the high cost of certain treatments, particularly advanced prescription medications such as cyclosporine eye drops (Restasis) and lifitegrast (Xiidra). These treatments, while effective, may be prohibitively expensive for some patients, particularly in developing countries or regions with limited healthcare coverage. This cost barrier can limit access to treatment and reduce market growth, particularly among lower-income populations.

Another challenge is the lack of awareness and diagnosis of dry eye syndrome. While the condition is widespread, many people do not seek medical attention until the symptoms become severe. Additionally, the symptoms of dry eye syndrome can overlap with other eye conditions, making it difficult to diagnose accurately without proper evaluation by an eye care professional. The underdiagnosis of dry eye syndrome can lead to a lower demand for treatments and impact market growth.

 Direct Order Can Be Placed Through This Link [Exclusive Copy] @  https://www.emergenresearch.com/select-license/2706

Growth Factors of the Dry Eye Syndrome Market :

Despite these challenges, the dry eye syndrome market presents several growth opportunities. One significant growth factor is the ongoing development of new and innovative treatment options. Pharmaceutical companies are investing in research and development to create more effective and patient-friendly treatments for dry eye syndrome. For example, novel therapies that target the underlying causes of dry eye, such as inflammation or meibomian gland dysfunction, are gaining attention. The introduction of these new treatments is expected to expand the range of options available to patients and drive market growth.

 The report also discusses the key players involved in the market such as:

AbbVie, Inc.; Alcon Inc., Altaire Pharmaceuticals Inc., Boiron USA, Similasan Corporation, Scope Ophthalmics Ltd. Sun Pharmaceutical Industries Ltd.; Santen Pharmaceutical Co., Ltd.; AFT Pharmaceuticals; Johnson & Johnson Services, Inc.; Otsuka Pharmaceutical Co., Ltd.; Novartis AG; OASIS Medical.; Oyster Point Pharma, Inc., Bausch & Lomb Novartis AG, Johnson & Johnson Services, Inc., Carl Zeiss AG, and among others

The report provides a thorough estimation of the overall impact of the pandemic on the Dry Eye Syndrome Market and its vital segments. The report also discusses the impact of the pandemic across different regions of the market. It also offers a current and future assessment of the impact of the pandemic on the Dry Eye Syndrome Market

Dry Eye Syndrome Market Segment Analysis :

For the purpose of this report, Emergen Research has segmented the global dry eye syndrome market on the basis of type, drugs, distribution channel, and region:

Type Outlook (Revenue, USD Billion; 2019-2032)
Evaporative Dry Eye Syndrome
Aqueous Deficient Dry Eye Syndrome

Drugs Outlook (Revenue, USD Billion; 2019-2032)
Restasis
Xiidra
Cequa
Eysuvis
Others

Distribution Channel Outlook (Revenue, USD Billion; 2019-2032)
Hospital Pharmacies.
Retail Pharmacies.
Online Pharmacies.

Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA

 Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/dry-eye-syndrome-market

Explore More of this reports @

Dry Eye Syndrome Market Size @ https://www.emergenresearch.com/industry-report/dry-eye-syndrome-market/market-size

Dry Eye Syndrome Market Share @ https://www.emergenresearch.com/industry-report/dry-eye-syndrome-market/market-share

Dry Eye Syndrome Market Trends @ https://www.emergenresearch.com/industry-report/dry-eye-syndrome-market/market-trends

Dry Eye Syndrome Regional Market Demand @ https://www.emergenresearch.com/industry-report/dry-eye-syndrome-market/regional-market-demand

Dry Eye Syndrome Market Analysis @ https://www.emergenresearch.com/industry-report/dry-eye-syndrome-market/market-analysis

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.